The European Union is taking significant steps towards protecting and restoring our ocean’s health with the PHAROS project, a crucial part of the EU’s ambitious Ocean Mission. Aiming to achieve three key objectives by 2030, restoring marine ecosystems and biodiversity, eliminating ocean pollution, and creating a sustainable blue economy, PHAROS is set to bridge the development phase (ending in 2025) and the deployment phase (2026-2030).
PHAROS will conduct four demonstrations in the Atlantic, utilising a mix of newly developed Nature-Based Solutions (NBS) and Integrated Multi-Trophic Aquaculture (IMTA), specifically tailored to the local environment.
Company Details
- Founded
- -
- Address
- Las Palmas, Gran Canaria 35200, Es
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://pharosproject.eu
- Keywords
- Marine Biodiversity Restoration, Nature-Based Solutions, Marine Protected Areas, Ocean Restoration, Macroalgae cultivation, Invasive Species reduction, Aquaculture Cages, Artificial Reefs.
- HQ
- Las Palmas, Gran Canaria
Pharos Questions
Pharos's website is https://pharosproject.eu
Pharos's LinkedIn profile is https://es.linkedin.com/company/pharos-project
Pharos's industry is
Biotechnology Research
Pharos's top competitors are
Osigu,
Icorsa,
Alpha-9 Oncology,
Avencell,
Ortholazer,
Oncolens,
Seaport Therapeutics,
4tissue,
Starget Pharma,
Mpath Health.
Pharos's categories are Biotechnology Research
Pharos's founding year is 2024
